Option Care es la primera compañía de terapias de infusión en el hogar del país que logra obtener la acreditación PCAB para todas las farmacias de fórmulas magistrales
By: Option Care
October 3, 2017
BANNOCKBURN, Ill., Oct. 3, 2017 — Option Care Enterprises, Inc., one of the leading providers of home and alternate treatment site infusion therapy services, is the first national home infusion company to achieve accreditation at each of its compounding pharmacies by the Pharmacy Compounding Accreditation Board (PCAB). This ensures they meet or exceed the most rigorous standards.
The accreditation verifies all Option Care cleanroom pharmacies — in which sterile compounding of intravenous (IV) medications for specific physician orders is performed — meet the highest-level standards, far and above what is required in most states. A service of Accreditation Commission for Health Care (ACHC), PCAB accreditation offers the most comprehensive compliance solution in the industry based on more than 40 sterile compounding standards in the U.S. Pharmacopeial Convention (USP) guidelines, or USP 797.
Si bien ya contaba con la acreditación general ACHC, otorgada a organizaciones del área de cuidados médicos que cumplen con los requerimientos normativos y los estándares de acreditación, Option Care buscó la acreditación PCAB para sus farmacias donde se preparan los compuestos debido a su dedicación que busca superar los estándares a través de un mejoramiento continuo de la calidad.
“PCAB accreditation of all of our compounding pharmacies provides an objective, external validation of our commitment to quality,” said Brenda Wright, Vice President of Clinical Services, Option Care. “Going above and beyond what is required is what we do. It’s how we approach our clinical services from the perspective of total quality management. This accreditation speaks to our pledge to drive continuous quality improvement and provide optimal outcomes for our patients.”
La acreditación PCAB contiene una extensa encuesta presencial conducida por un experto independiente para asegurar el cumplimiento con el proceso de preparación de compuestos farmacéuticos estériles y no estériles, estipulado en los estándares USP 795 y USP 797. ACHC nota que la acreditación PCAB junto con el compromiso de la farmacia por el continuo cumplimiento reduce de manera significativa el riesgo asociado con los medicamentos formulados y demuestra un compromiso por cumplir los estándares más altos de la industria en cuanto a calidad y seguridad.
“We are thrilled that Option Care has chosen to leverage the breadth of pharmacy accreditation programs ACHC offers,” said José Domingos, CEO of ACHC. “This demonstrates a commitment to delivering quality care for patients.”
La acreditación PCAB se da tras la obtención de otro logro: la acreditación URAC de farmacia especializada con un puntaje perfecto del 100 por ciento para los centros corporativos, así como para los tres centros de excelencia de farmacia especializada de Option Care.
Acerca de ACHC
ACHC is a non-profit organization that has stood as a symbol of quality and excellence since 1986. ACHC is the provider’s choice for compliance solutions because of its personal Account Advisors, relevant and realistic standards, competitive pricing, and a friendly, consultative approach to accreditation. Beginning July 2014, PCAB became a service of ACHC, offering programs for non-sterile (ref. USP 795) and sterile (ref. USP 797) compounding services. PCAB assesses the compounding process based on a specific set of standards that concentrate on the quality and consistency of compounded medications while incorporating performance improvement and ongoing compliance requirements. PCAB Accreditation reflects an organization’s dedication and commitment to meeting standards that facilitate a higher level of performance and patient care. For more information on ACHC’s accreditation programs and educational resources, or to download ACHC accreditation standards, visit www.achc.org.
Acerca de Option Care
Option Care Enterprises, Inc. (Option Care) is one of the nation’s largest and most trusted providers of home and alternate treatment site infusion services. An industry leader, the company draws on nearly 40 years of clinical care experience to offer patient-centered therapy management. Option Care’s signature Home Infusion Plus services include the clinical management of infusion medicines, nursing support and care coordination. Option Care’s multidisciplinary team of more than 1,800 clinicians — including pharmacists, nurses and dietitians — are able to provide home infusion service coverage for nearly all patients across the United States needing treatment for complex and chronic conditions. Learn more at www.OptionCare.com.
You might also be interested in:
Option Care seleccionado para brindar el primer y único tratamiento específicamente para deficiencia hereditaria de factor X
DEERFIELD, Ill. — Option Care Enterprises, Inc., an independent infusion services company, has been selected as a contracted provider of Coagadex ® (Coagulation Factor X Human), the first and only treatment approved by the U.S. Food and Drug Administration specifically for hereditary factor X deficiency, a rare and serious bleeding disorder. Coagadex is manufactured by […]
Los pacientes de Option Care que reciben infusión en el hogar de inmunoglobulina se benefician de mejores resultados y menores costos
SAN ANTONIO — Option Care patients treated with immunoglobulin (IG) therapy at home with a high level of clinical oversight had better outcomes compared to others receiving the therapy according to a first-of-its-kind study presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting this week. The researchers, who evaluated data […]